Related Experiment Video
Updated: Sep 4, 2025

Visualization of Twitching Motility and Characterization of the Role of the PilG in Xylella fastidiosa
Published on: April 8, 2016
Characterization of Pseudomonas aeruginosa Bacteriophage L5 Which Requires Type IV Pili for Infection
Lan Yang1, Tingting Zhang1,2, Linlin Li1
1Shanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Abstract:
Pseudomonas aeruginosa is a common opportunistic human pathogen. With the emergence of multidrug-resistant (MDR) clinical infection of P. aeruginosa, phage therapy has received renewed attention in treating P. aeruginosa infections. Moreover, a detailed understanding of the host receptor of lytic phage is crucial for selecting proper phages for therapy. Here, we describe the characterization of the P. aeruginosa bacteriophage L5 with a double-stranded DNA genome of 42,925 bp. The genomic characteristics indicate that L5 is a lytic bacteriophage belonging to the subfamily Autographivirinae. In addition, the phage receptors for L5 were also identified as type IV pili, because the mutation of pilZ, which is involved in pili synthesis, resists phage infection, while the complementation of pilZ restored its phage sensitivity. This research reveals that L5 is a potential phage therapy candidate for the treatment of P. aeruginosa infection.
Insights
This study characterizes Pseudomonas aeruginosa bacteriophage L5, identifying type IV pili as its host receptor. This finding supports L5 as a potential phage therapy candidate against multidrug-resistant Pseudomonas aeruginosa infections.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Pseudomonas aeruginosa is a significant opportunistic pathogen, frequently causing multidrug-resistant (MDR) infections.
- Phage therapy is regaining interest for treating MDR bacterial infections, necessitating understanding of phage-host interactions.
- Identifying specific phage receptors is critical for effective phage therapy selection.
Purpose of the Study:
- To characterize the bacteriophage L5 infecting Pseudomonas aeruginosa.
- To determine the host receptor utilized by phage L5 for infection.
Main Methods:
- Genomic sequencing and analysis of bacteriophage L5.
- Identification of phage receptors through genetic analysis of Pseudomonas aeruginosa mutants.
- Mutation and complementation studies of the pilZ gene involved in type IV pili synthesis.
Main Results:
- Phage L5 possesses a double-stranded DNA genome (42,925 bp) and belongs to the Autographivirinae subfamily.
- Type IV pili were identified as the specific host receptors for phage L5.
- Mutations in pilZ, essential for pili synthesis, conferred resistance to phage L5 infection, which was restored upon complementation.
Conclusions:
- Phage L5 is a lytic bacteriophage with potential for treating Pseudomonas aeruginosa infections.
- The identification of type IV pili as L5 receptors provides crucial information for phage therapy applications.
- Further research into L5 and its receptor interactions can advance phage therapy strategies against P. aeruginosa.
Related Concept Videos
Fimbriae, Pili, and Axial Filaments
Lytic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle

